After graduating from Loyola University Chicago in 2004, Dr. Lawlor completed a residency in Anatomic Pathology and a fellowship in Neuropathology at Massachusetts General Hospital/Harvard Medical School, and has since become board-certified in both of these fields. Dr. Lawlor pursued postdoctoral research training in the laboratory of Dr. Alan Beggs at Children’s Hospital Boston, where he focused on the pathological analysis of animal models of muscle disease and the development of treatments for X-linked myotubular myopathy.
Since moving to the Medical College of Wisconsin September of 2011, Dr. Lawlor has continued to work closely with the Beggs laboratory while establishing clinical and research neuromuscular pathology laboratories. The work performed in his research laboratory at MCW has performed the pathological analyses for a number of preclinical trial studies for animal models of X-linked myotubular myopathy that are currently being performed worldwide, including anti-myostatin therapy, gene therapy, and protein replacement therapy. He has also recently begun evaluating myostatin inhibition in murine models of nemaline myopathy.
In the spring of 2013, Dr. Lawlor’s laboratory became the site of the Congenital Muscle Disease Tissue Repository, which is meant to provide a central place for the donation and distribution of patient tissues, thanks to a generous donation by a collection of non-profit organizations. It is our hope that such a central resource for tissue storage and distribution will improve the pace of research in our field.
2012, Boston Children's Hospital, Research Fellowship
2004, Loyola Univ of Chicago-Stritch School of Med, MD
2004, Loyola University of Chicago (IL), PhD
2008, Massachusetts General Hospital - Anatomic/Clinical pathology
2012, Boston Children's Hospital - Pediatrics
2008, Massachusetts General Hospital - Neuropathology
1996: Phi Beta Kappa
2001-2002: Schmitt Dissertation Fellowship, Loyola University Chicago
2008: Awarded a travel award for the 2008 meeting of the World Muscle Society. This award was declined because the meeting was on the same day as the neuropathology Board Exam.
July 2010-2015: Awarded a K08 Mentored Clinical Scientist Development Award from the NIAMS for a project entitled “Mechanisms and efficacy of myostatin inhibition in myotubular myopathy.” Mentor: Alan H. Beggs, Ph.D.
2011: Awarded a travel award for the 2011 meeting of the American Association of Neuropathologists
2012: Awarded the Weil Award for the Best Paper in Experimental Neuropathology at the 2012 American Association of Neuropathologists meeting for the presentation entitled “Ultrastructural pathology and functional deficits can be reversed following enzyme-replacement in myotubularin-deficient mice”
2012: Awarded the Best Basic Science Junior Faculty Poster at the Medical College of Wisconsin Research Day for the poster entitled “Ultrastructural pathology and functional deficits can be reversed following enzyme-replacement in myotubularin-deficient mice”
2012: Placed on M Magazine’s 2013 Top-Rated Doctors list, which lists the top 10% rated doctors in the metropolitan Milwaukee area